-
An orally active kinase inhibitor is available for patients with chronic myeloid leukemia (CML) or Philadelphia chromosome positive acute lymphoblastic leukemia who are intolerant or resistant to prior therapy with imatinib.
-
The ECG image in the article was obtained from a middle-aged woman with shortness of breath. She is a long-time heavy smoker.
-
Because of adverse effects, special care should be used when prescribing the atypical antipsychotic drugs for patients with dementia.
-
This study addresses the role of nutritional status in the disablement process. Low serum concentrations of vitamins B6, B12 and selenium seem to predict subsequent disability in activities of daily living (ADLs) in older women living in the community.
-
Evaluation of a large United Kingdom (UK) database supports a dose-related association with hip fracture. There appears to be a correlation between PPI use, including dosage and chronicity, and occurrence of hip fractures in patients over age 50.
-
The FDA has approved a new atypical antipsychotic agent. Paliperidone is the active metabolite of risperidone. The drug is formulated in an osmotic drug delivery system (OROS) developed by ALZA.
-
The Finnish Diabetes Prevention Study (FDPS) demonstrated that a program of diet and exercise was capable of reducing the incidence of diabetes by approximately 60% in persons with impaired fasting glucose (IFG) or impaired glucose tolerance (IGT), compared to placebo.
-
Searching Google yielded a correct diagnosis in greater than half of cases.
-
-
